News & Updates

Show Multimedia Only
Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab

Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab

15 Jul 2023

Time to recovery from COVID-19 pneumonia does not appear to differ following treatment with abatacept, cenicriviroc, or infliximab among hospitalized patients, according to a study.

15 Jul 2023
Danuglipron helps with glucose control, weight loss in T2D

Danuglipron helps with glucose control, weight loss in T2D

15 Jul 2023 byJairia Dela Cruz

The glucagon-like peptide 1 receptor (GLP-1R) agonist danuglipron appears to be beneficial in the treatment of patients with type 2 diabetes (T2D), yielding reductions in glycated haemoglobin (HbA1c), fasting plasma glucose (FPG), and body weight, without fasting restrictions, as shown in the results of a phase IIb study.

15 Jul 2023
Long-acting ART induces viral suppression in people with HIV

Long-acting ART induces viral suppression in people with HIV

15 Jul 2023

People with HIV (PWH) who are treated with long-acting (LA) antiretroviral therapy (ART) achieve virologic suppression, as do those with viraemia and challenges to adherence, reports a study.

15 Jul 2023